Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early glaucoma detection in babies could save sight, study hints

NCT ID NCT03077789

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 250 children under 4 years old with congenital glaucoma in France. Researchers wanted to see if finding the disease earlier leads to better eyesight at age 4. They measured vision and eye pressure to understand how timing of diagnosis affects long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better early detection programs for congenital glaucoma, improving long-term vision in affected children.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove that earlier diagnosis directly causes better vision, only that they are linked.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2013

Finished

Nov 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 4 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Boys or girls under the age of 4, without antecedent, French or resident in France, Suspected Glaucoma Exclusion Criteria: * Antecedent of surgery for glaucoma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital glaucoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aphm Hopital Nord

    Marseille, France

  • CHRU Besançon

    Besançon, France

  • CHRU de Montpellier

    Montpellier, France

  • CHRU de Tours

    Tours, France

  • CHRU, Hôpital Claude Huriez

    Lille, France

  • CHU Bordeaux

    Bordeaux, France

  • CHU Dijon Bourgogne

    Dijon, France

  • CHU de Clermont-Ferrand

    Clermont-Ferrand, France

  • CHU de Montpellier

    Montpellier, France

  • CHU de Toulouse

    Toulouse, France

  • Centre Hospitalier Regional D' Angers

    Angers, France

  • Centre Hospitalier Universitaire

    Nantes, France

  • Chru Rennes Site Pontchaillou

    Rennes, France

  • Chu Amiens Picardie

    Amiens, France

  • Chu Amiens Picardie - Amiens 1

    Amiens, France

  • Chu de Grenoble Alpes

    Grenoble, France

  • Chu de Nice Hopital de L'Archet

    Nice, France

  • Chu de Tours

    Tours, France

  • Fondation de Rothschild - Paris

    Paris, France

  • Hopital Charles Nicolle Chu Rouen

    Rouen, France

  • Hopital Civil / Nouvel Hopital Civil - Strasbourg

    Strasbourg, 67091, France

  • Hopital Edouard Herriot - Hcl - Lyon 03

    Lyon, 69008, France

  • Hopital Robert Debre Chu Reims

    Reims, France

  • Hu Necker Enfants Malades Aphp - Paris 15

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.